• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哥伦比亚社区获得性肺炎患者3个月、6个月和12个月的生存率:一项回顾性队列研究。

Survival at 3, 6 and 12 months in patients diagnosed with community-acquired pneumonia in Colombia: a retrospective cohort study.

作者信息

Tuta-Quintero Eduardo, Torres-Arevalo Daniela, Bastidas-Goyes Alirio Rodrigo, Aponte-Murcia Hermencia C, Guerrero Manuela, Giraldo Andrea, Villarraga Laura, Orjuela Laura, Hernández Juan, Giraldo-Cadavid Luis F

机构信息

Universidad de La Sabana, School of Medicine, Chía, Colombia.

Universidad de La Sabana, School of Medicine, Chía, Colombia.

出版信息

Braz J Infect Dis. 2024 Jul-Aug;28(4):103852. doi: 10.1016/j.bjid.2024.103852. Epub 2024 Jul 20.

DOI:10.1016/j.bjid.2024.103852
PMID:39043283
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11327535/
Abstract

BACKGROUND

The primary aim of this study is to assess the survival rates of individuals diagnosed with Community-Acquired Pneumonia (CAP) post-hospitalization in Colombia. Additionally, explore potential risk factors associated with decreased long-term survival.

METHODS

A retrospective cohort study was conducted in a hospital in Colombia, evaluating survival at 3, 6 and 12 months in CAP patients, using the Kaplan-Meier method. Stratifications were made by age, sex, comorbidity, and severity. The comparison of survival curves was performed using the Log-Rank test, a multivariate analysis with Cox regression was performed to study possible risk factors that affected 12-month survival in patients with CAP.

RESULTS

3688 subjects were admitted, with a mortality of 16.3 % per year. Survival at three, six, and twelve months was 92.9 % (95 % CI 92-93 %), 88.8 % (95 % CI 87-90 %), and 84.2 % (95 % CI 82-85 %), respectively. Analysis stratified by pneumonia severity index, 12-month survival was 98.7 % in Class I, 95.6 % in Class II, 87.41 % in Class III, 77.1 % in Class IV, and 65.8 % in class-V (p < 0.001). Cox-regression showed that being male (HR = 1.44; 95 % CI 1.22‒1.70; p < 0.001), an elevated pneumonia severity index (HR = 4.22; 95 % CI 1.89‒9.43; p < 0.001), a high comorbidity index (HR = 2.29; 95 % CI 1.89‒2.84; p < 0.001) and vasopressor requirement (HR = 2.22; 95 % CI < 0.001) were associated with a lower survival at twelve months of follow-up.

CONCLUSION

Survival in patients with CAP who require hospitalization decreases at 3, 6, and 12 months of follow-up, being lower in patients older than 65 years, men, high comorbidity, and in subjects with severe presentation of the disease.

摘要

背景

本研究的主要目的是评估哥伦比亚社区获得性肺炎(CAP)患者出院后的生存率。此外,探索与长期生存率降低相关的潜在风险因素。

方法

在哥伦比亚的一家医院进行了一项回顾性队列研究,采用Kaplan-Meier方法评估CAP患者3个月、6个月和12个月的生存率。按年龄、性别、合并症和严重程度进行分层。使用对数秩检验比较生存曲线,进行多变量Cox回归分析以研究影响CAP患者12个月生存率的可能风险因素。

结果

共纳入3688名受试者,年死亡率为16.3%。3个月、6个月和12个月的生存率分别为92.9%(95%CI 92-93%)、88.8%(95%CI 87-90%)和84.2%(95%CI 82-85%)。根据肺炎严重程度指数分层分析,I级患者12个月生存率为98.7%,II级为95.6%,III级为87.41%,IV级为77.1%,V级为65.8%(p<0.001)。Cox回归显示,男性(HR=1.44;95%CI 1.22‒1.70;p<0.001)、肺炎严重程度指数升高(HR=4.22;95%CI 1.89‒9.43;p<0.001)、高合并症指数(HR=2.29;95%CI 1.89‒2.84;p<0.001)和血管升压药需求(HR=2.22;95%CI<0.001)与随访12个月时较低生存率相关。

结论

需要住院治疗的CAP患者在随访3个月、6个月和12个月时生存率下降,65岁以上患者、男性、合并症高以及疾病表现严重的患者生存率更低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c27f/11327535/a0120e65dae1/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c27f/11327535/4acc75b5af36/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c27f/11327535/b89b54cb233d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c27f/11327535/f6f5a3bb9466/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c27f/11327535/c94cf1c667fb/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c27f/11327535/a0120e65dae1/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c27f/11327535/4acc75b5af36/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c27f/11327535/b89b54cb233d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c27f/11327535/f6f5a3bb9466/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c27f/11327535/c94cf1c667fb/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c27f/11327535/a0120e65dae1/gr5.jpg

相似文献

1
Survival at 3, 6 and 12 months in patients diagnosed with community-acquired pneumonia in Colombia: a retrospective cohort study.哥伦比亚社区获得性肺炎患者3个月、6个月和12个月的生存率:一项回顾性队列研究。
Braz J Infect Dis. 2024 Jul-Aug;28(4):103852. doi: 10.1016/j.bjid.2024.103852. Epub 2024 Jul 20.
2
Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study.社区获得性肺炎住院后的长期发病率和死亡率:一项基于人群的队列研究。
Medicine (Baltimore). 2008 Nov;87(6):329-334. doi: 10.1097/MD.0b013e318190f444.
3
Performance of risk scores in predicting mortality at 3, 6, and 12 months in patients diagnosed with community-acquired pneumonia.风险评分在预测社区获得性肺炎患者 3、6 和 12 个月死亡率中的表现。
BMC Pulm Med. 2024 Jul 10;24(1):334. doi: 10.1186/s12890-024-03121-7.
4
Community-acquired pneumonia and survival of critically ill acute exacerbation of COPD patients in respiratory intensive care units.社区获得性肺炎与慢性阻塞性肺疾病患者在呼吸重症监护病房严重急性加重期的生存情况
Int J Chron Obstruct Pulmon Dis. 2016 Aug 9;11:1867-72. doi: 10.2147/COPD.S113510. eCollection 2016.
5
The Impact of Age and Comorbidities on the Mortality of Patients of Different Age Groups Admitted with Community-acquired Pneumonia.年龄和合并症对不同年龄组因社区获得性肺炎入院患者死亡率的影响。
Ann Am Thorac Soc. 2016 Sep;13(9):1519-26. doi: 10.1513/AnnalsATS.201512-848OC.
6
Impact of prior pulmonary tuberculosis in treatment outcomes of HCAP and CAP patients in intensive care units.重症监护病房中既往肺结核对 HCAP 和 CAP 患者治疗结局的影响。
J Microbiol Immunol Infect. 2019 Apr;52(2):320-328. doi: 10.1016/j.jmii.2018.08.012. Epub 2018 Sep 5.
7
Decrease in long-term survival for hospitalized patients with community-acquired pneumonia.社区获得性肺炎住院患者的长期生存率下降。
Chest. 2010 Aug;138(2):279-83. doi: 10.1378/chest.09-2702. Epub 2010 Apr 9.
8
[Incidence and risk factors for cardiovascular events in patients hospitalized with community-acquired pneumonia].社区获得性肺炎住院患者心血管事件的发生率及危险因素
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Mar 24;48(3):228-235. doi: 10.3760/cma.j.cn112148-20190617-00342.
9
RDW-based clinical score to predict long-term survival in community-acquired pneumonia: a European derivation and validation study.基于红细胞分布宽度的临床评分预测社区获得性肺炎的长期生存:一项欧洲的推导和验证研究。
Intern Emerg Med. 2021 Sep;16(6):1547-1557. doi: 10.1007/s11739-020-02615-6. Epub 2021 Jan 11.
10
Why mortality is increased in health-care-associated pneumonia: lessons from pneumococcal bacteremic pneumonia.为什么医疗保健相关性肺炎的死亡率会增加:从肺炎球菌菌血症性肺炎中得到的教训。
Chest. 2010 May;137(5):1138-44. doi: 10.1378/chest.09-2175. Epub 2009 Dec 1.

本文引用的文献

1
Severe community-acquired pneumonia in the post COVID-19 era.新冠疫情后时代的重症社区获得性肺炎
Curr Opin Crit Care. 2023 Oct 1;29(5):400-406. doi: 10.1097/MCC.0000000000001083. Epub 2023 Jul 31.
2
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia.ERS/ESICM/ESCMID/ALAT 指南:严重社区获得性肺炎管理。
Intensive Care Med. 2023 Jun;49(6):615-632. doi: 10.1007/s00134-023-07033-8. Epub 2023 Apr 4.
3
New testing guidelines for community-acquired pneumonia.社区获得性肺炎的新检测指南。
Curr Opin Infect Dis. 2022 Apr 1;35(2):128-132. doi: 10.1097/QCO.0000000000000824.
4
Predictors of Long-term Outcomes in the Older Adults with Community-Acquired Pneumonia.老年人社区获得性肺炎的长期预后预测因素。
J Infect Dev Ctries. 2021 Dec 31;15(12):1910-1916. doi: 10.3855/jidc.14881.
5
Antibiotic prescription consistent with guidelines in emergency department is associated with 30-day survival in severe community-acquired pneumonia.抗生素处方符合急诊指南与严重社区获得性肺炎 30 天生存率相关。
BMC Emerg Med. 2021 Sep 27;21(1):108. doi: 10.1186/s12873-021-00505-4.
6
Community-acquired pneumonia.社区获得性肺炎。
Lancet. 2021 Sep 4;398(10303):906-919. doi: 10.1016/S0140-6736(21)00630-9.
7
Burden of pneumococcal pneumonia requiring ICU admission in France: 1-year prognosis, resources use, and costs.法国需要入住 ICU 的肺炎球菌性肺炎负担:1 年预后、资源利用和成本。
Crit Care. 2021 Jan 10;25(1):24. doi: 10.1186/s13054-020-03442-z.
8
International Perspective on the New 2019 American Thoracic Society/Infectious Diseases Society of America Community-Acquired Pneumonia Guideline: A Critical Appraisal by a Global Expert Panel.国际视角下的新版 2019 美国胸科学会/美国传染病学会社区获得性肺炎指南:全球专家小组的批判性评估。
Chest. 2020 Nov;158(5):1912-1918. doi: 10.1016/j.chest.2020.07.089. Epub 2020 Aug 25.
9
Burden of Community-Acquired Pneumonia and Unmet Clinical Needs.社区获得性肺炎负担和未满足的临床需求。
Adv Ther. 2020 Apr;37(4):1302-1318. doi: 10.1007/s12325-020-01248-7. Epub 2020 Feb 18.
10
Factors influencing long-term survival after hospitalization with pneumococcal pneumonia.影响肺炎链球菌性肺炎住院后长期生存的因素。
J Infect. 2019 Dec;79(6):542-549. doi: 10.1016/j.jinf.2019.10.024. Epub 2019 Nov 5.